Prof Dr P. Lambin
- Co-founder and Shareholder (minority) at Convert Pharmaceuticals
- Member of the Scientific Advisory Board at The Institute of Cancer Research
- Member of the Advisory Board at Benelux Health Ventures SPRL
- Member of the external Scientific Advisory Board at CRUK Lung Cancer Center of Excellence
- Scientific Advisory Board (CSA), member of the board, CEO ad interim at Convert Pharmaceuticals
- Co-founder and Shareholder (minority) at Oncoradiomics S.A.
- Scientific advisor, minority Shareholder, member of the board at Comunicare
- Shareholder (minority) at LivingMed Biotech
- Scientific advisor, Minority shareholder & Member of the board at Bactam
- Member of the board at Oncoradiomics S.A.
- Scientific Advisor at Institut Jules Bordet, ULB
- Chief Scientific Advisor, board member at LivingMed Biotech
- Consultant at Roche
Memberships:
Nederlandse Vereniging voor Radiotherapie en Oncologie (NVRO)
Belgische Vereniging voor Radiotherapie en Oncologie (BVRO)
Nederlandse Vereniging voor Radiobiologie (NVRB)
Radiation Research Society (RRS)
American Association for Cancer Research (AACR)
European Society for Therapeutic Radiology and Oncology (ESTRO)
American Society for Therapeutic Radiology and Oncology (ASTRO)
Prof Dr P. Lambin
MD, PhD, RadOnc & Principal Investigator in the Dpt of Precision Medicine (www.precisionmedicine.eu):The D-Lab (data sciences lab), the M-Lab group (biology lab) and The Clinical Trial Unit (Phase 1, 2 Clinical trials, prospective studies and "In Silico" Clinical trials)
Precision Medicine
GROW, School for Oncology & Reproduction
Fac. Health, Medicine and Life Sciences